Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients
- 1 January 1992
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 15 (1) , 3-14
- https://doi.org/10.1016/0168-8227(92)90060-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitusDiabetes Research and Clinical Practice, 1992
- Regional distribution and molecular forms of rat islet amyloid polypeptideBiochemical and Biophysical Research Communications, 1990
- Failure of islet amyloid polypeptide to inhibit basal and glucose‐stimulated insulin secretion in model experiments in mice and ratsActa Physiologica Scandinavica, 1990
- Isolation and sequence determination of ratislet amyloid polypeptideBiochemical and Biophysical Research Communications, 1989
- Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentrationBiochemical and Biophysical Research Communications, 1989
- In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbitBiochemical and Biophysical Research Communications, 1989
- EXPRESSION OF THE RAT AMYLIN (IAPP / DAP) GENE.Journal of Molecular Endocrinology, 1989
- Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic isletsBiochemical and Biophysical Research Communications, 1989
- Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitroNature, 1988
- ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETESThe Lancet, 1987